About this trial
Evaluation of variation of mineral density and bone microarchitecture after allogeneic HSCTs transplant in hematologic malignancies. Comparison with the general population.
Eligibility criteria
Qualifiers
Cytological diagnosis of acute myeloid leukemia (AML) with indication for a first-line allo-HSCTs transplant
Patient affiliated to the social security system
For women of childbearing age, use of reliable contraception throughout the study in accordance with the CPR of the drugs used.
The patient must be able to comply with study visits and per protocol procedures
Disqualifiers
Person under guardianship or curatorship, or unable to understand the purpose of the study.
Hematologic malignancies other than AML
History of neoplasia with bone involvement (sarcoma, multiple myeloma, metastasis...) and/or any solid cancer less than 5 years old
History of fracture of the femoral neck prior to the diagnosis of hematologic malignancies
Trial design
Treatments tested in this trial
- Bone osteodensitometry